You have the right to appeal, which typically involves submitting additional clinical documentation, peer-to-peer review (your doctor speaking directly with an insurer's medical director), or an independent external review
Whether GHK-Cu is appropriate for you is a clinical determination made by a licensed provider during evaluation
Current Melanotan II peptide research focuses on melanocortin receptor-associated signaling, pigmentation-related cellular pathways, and neuroendocrine signaling mechanisms studied in controlled laboratory and in vitro environments
Other important side effects include gallbladder disease (cholelithiasis, cholecystitis), and potential worsening of diabetic retinopathy (particularly with rapid HbA1c reduction on semaglutide)
Also, you can keep a photo record of your skin before and during the treatment to objectively track any changes